Takeover

Acquirers

Resistance Acquisition, Inc.

Targets
1
Filings
3
Median premium
116%
First filing
Jun 30, 2023
Latest filing
Aug 2, 2023

Targets

CompanyScore before dealScore nowFilingsLatest
Paratek Pharmaceuticals, Inc.1 / 7—3Aug 2, 2023

Deal filings

FiledCompanyFormPricePremium
Aug 2, 2023Paratek Pharmaceuticals, Inc.DEFM14A$2.15115.79%
Jun 30, 2023Paratek Pharmaceuticals, Inc.SC 13E3——
Jun 30, 2023Paratek Pharmaceuticals, Inc.PREM14A$2.15115%